Adult bone marrow stem cells for cell and gene therapies: Implications for greater use

Journal of Cellular Biochemistry

Volumn 85, Issue SUPPL. 38, 2002, Pages 20-28

  Moore, Malcolm A S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bone marrow; Cell therapy; Gene therapy; Stem cells

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL TYPE; GENE THERAPY; HEMATOPOIETIC STEM CELL; MESENCHYME CELL; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION; ANIMAL; BIOLOGICAL THERAPY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CYTOLOGY; GENETIC DISORDER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; MULTIPOTENT STEM CELL; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL LINEAGE; GENE THERAPY; GENETIC DISEASES, INBORN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MULTIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

EID: 37649026269     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10127     Document Type: Article

References (47)

1. Acceleration of experimental endochondral ossification by biophysical stimulation of the progenitor cell pool
2. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
3. Building a meniscus. Biologic considerations
4. In vitro characterization of mesenchymal stem cell-seeded ollagen scaffolds for tendon repair: Effects of initial seeding density on contraction kinetics
5. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
6. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo
7. The evolving concept of a stem cell: Entity or function?
8. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation
9. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells
10. Perspectives on cell and collagen composites for tendon repair
11. Mesenchymal stem cells and gene therapy
12. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century
13. Gene therapy of wounds with growth factors
14. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection
15. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
16. Directed differentiation of dendritic cells from mouse embryonic stem cells
17. Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells
18. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy
19. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells
20. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
21. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor
22. Hematopoietic potential of stem cells isolated from murine skeletal muscle
23. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
24. A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells
25. Mesenchymal stem cells: Heading into the clinic
26. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
27. Circulating skeletal stem cells
28. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections
29. G156a mgmt-transduced human mesenchymal stem cells can be selectively enriched by o6-benzylguanine and bcnu
30. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
31. Exogenously regulated stem cell mediated gene therapy for bone regeneration
32. Transfer of proalpha2(I) cDNA into cells of a murine model of human osteogenesis imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo
33. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites
34. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta
35. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
36. Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector
37. A new look at the origin, function, and "stem-cell" status of muscle satellite cells
38. Skinny dipping for stem cells
39. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice
40. Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype
41. The neural stem cells and their transdifferentiation capacity
42. Directed endothelial differentiation of cultured embryonic yolk sac cells in vivo provides a novel cell-based system for gene therapy
43. Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells
44. Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia
45. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
46. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice
47. Mesenchymal precursor cells in the blood of normal individuals